Smoking ups risk of some renal cell cancer histological subtypes

August 17, 2015

Smoking ups risk of some renal cell cancer histological subtypes
(HealthDay)—Smoking is a risk factor for clear cell and papillary renal cell carcinoma, but not for the chromophobe subtype, according to a study published in the September issue of The Journal of Urology.

Neel H. Patel, M.D., from the State University of New York in Buffalo, and colleagues examined the correlation between smoking and subtype. Data were collected from 816 patients with nonfamilial renal cell carcinoma (705) or benign pathology (111) undergoing nephrectomy.

The researchers found that 51 percent of patients reported smoking, including 21 percent active smokers and 30 percent former smokers. Compared with benign histology, active smoking was more common with clear cell or papillary cell carcinoma (23 and 26 percent, respectively, versus 14 percent; P < 0.05 each). Active smoking was less common with chromophobe renal cell carcinoma (6 percent; P < 0.05 versus clear cell or papillary). Any history was also less common with chromophobe versus clear cell or papillary histology (26 percent versus 53 percent [P = 0.003] or 58 percent [P = 0.001]). For clear cell and papillary histologies, but not chromophobe histology, independent associations with persisted after multivariable adjustment (odds ratios, 2.2 and 2.4, respectively; both P < 0.05).

"These findings underscore distinct carcinogenic mechanisms underlying the various renal cell carcinoma subtypes," the authors write.

Explore further: Smoking adversely impacts renal cell carcinoma survival

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Smoking adversely impacts renal cell carcinoma survival

February 27, 2014
(HealthDay)—For patients with clear cell renal cell carcinoma, smoking exposure adversely impacts cancer-specific survival and increases the risk of death from another cause, according to a study published in the March ...

Statins may reduce risk of progression of renal cancer

April 23, 2014
(HealthDay)—Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research published in the April issue of The Journal of Urology.

Study clarifies best treatments for uncommon kidney cancers

May 18, 2015
A head-to-head comparison of two biologic therapies used to treat a subset of patients with advanced kidney cancers provides much-needed clarity on the preferred treatment for the first line of attack.

Limited resection generally not equivalent in stage IA NSCLC

August 9, 2015
(HealthDay)—For older patients with invasive, stage IA non-small-cell lung cancer, limited resection is generally not equivalent to lobectomy, according to a study published online Aug. 3 in the Journal of Clinical Oncology.

Chemical shift MRI helps differentiate renal cell tumors more likely to metastasize

April 19, 2013
Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians better determine treatment ...

Recommended for you

Two ways cancer resists treatment are actually connected, with one activating the other

December 18, 2018
Drugs that target BRAF and MEK in cancer have shown promise in treating a subset of melanoma that carries a mutation in the BRAF gene, but drug resistance usually emerges, reversing the benefit of these drugs and limiting ...

HPV discovery raises hope for new cervical cancer treatments

December 18, 2018
Researchers at the University of Virginia School of Medicine have made a discovery about human papillomavirus (HPV) that could lead to new treatments for cervical cancer and other cancers caused by the virus.

Vaccine, checkpoint drugs combination shows promise for pancreatic cancers

December 18, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people ...

Researchers identify ways breast cancer avoids immune system detection

December 18, 2018
Recent breakthroughs in immunotherapy are making a huge difference in treating some forms of cancer, especially metastatic cancer. But breast cancer has proven a tricky foe for this new therapy, and an interdisciplinary team ...

Metal chemotherapy drugs boost the impact of immunotherapy in cancer

December 18, 2018
Due to their powerful tumour-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) ...

10-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

December 17, 2018
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.